Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
AFAcutus Medical, Inc. logo

Acutus Medical, Inc. (AFIB)

Other OTC · Currency in USD
$0.00 ▲ +0.00 (+0.00%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.00
Open
$0.00
Day's Range
$0.00 – $0.00
52 Week Range
$0.00 – $0.01
Volume
10,000
Avg. Volume
17,649
Market Cap
$2.99K
Beta (5Y Monthly)
5.77
PE Ratio (TTM)
--
EPS (TTM)
-$0.32
Earnings Date
Nov 13, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$1.50

Profile: Acutus Medical, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
85
CEO
Takeo Mukai

Acutus Medical, Inc. is a company dedicated to the treatment of cardiac arrhythmias, focusing on the design, manufacturing, and commercialization of specialized tools for catheter-based ablation procedures. These solutions are utilized to manage a spectrum of heart rhythm disorders across both domestic U.S. and international markets. The firm's extensive product offerings include innovative access sheaths, transseptal crossing devices, diagnostic and mapping catheters, along with both traditional and contact-force ablation catheters.

Earnings

Next report: Fri, Nov 13, 2026
EPS estimate -$0.95 · Revenue est. $2.79M
DateEst.Actual
Apr 3, 2025-$0.40-$0.04Beat
Mar 24, 2025–-$0.05
Nov 14, 2024–-$0.03
Aug 8, 2024–-$0.01
May 9, 2024–-$0.07
Apr 1, 2024-$0.39-$1.15Miss

Analyst view

Consensus price target
$1.50 ▲ +1,499,900.0%
Range $1.50 – $1.50
Rating: Hold
Buy 17% · Hold 67% · Sell 17%

Get free alerts on AFIB and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.